Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary InterventionHeping Lei, Shilong Zhong, Wanping Zhong et al.|Clinical Pharmacokinetics|2017Cited by 17
Plasma MIR-142 Accounting for the Missing Heritability of <i>CYP3A4/5</i> Functionality is Associated with Pharmacokinetics of ClopidogrelQian-Jie Tang, Laiyou Wang, Haoming Lin et al.|Pharmacogenomics|2016Cited by 7